| Association of black race with prostate cancer–specific and other-cause mortality RT Dess, HE Hartman, BA Mahal, PD Soni, WC Jackson, MR Cooperberg, ... JAMA oncology 5 (7), 975-983, 2019 | 362 | 2019 |
| Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies WC Jackson, J Silva, HE Hartman, RT Dess, AU Kishan, WH Beeler, ... International Journal of Radiation Oncology* Biology* Physics 104 (4), 778-789, 2019 | 307 | 2019 |
| Combining urinary detection of TMPRSS2: ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer SS Salami, F Schmidt, B Laxman, MM Regan, DS Rickman, D Scherr, ... Urologic Oncology: Seminars and Original Investigations 31 (5), 566-571, 2013 | 291 | 2013 |
| Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy AR Rastinehad, B Turkbey, SS Salami, O Yaskiv, AK George, M Fakhoury, ... The Journal of urology 191 (6), 1749-1754, 2014 | 235 | 2014 |
| In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12‐core biopsy still necessary in addition to a targeted biopsy? SS Salami, E Ben‐Levi, O Yaskiv, L Ryniker, B Turkbey, LR Kavoussi, ... BJU international 115 (4), 562-570, 2015 | 171* | 2015 |
| Association between combined TMPRSS2: ERG and PCA3 RNA urinary testing and detection of aggressive prostate cancer MG Sanda, Z Feng, DH Howard, SA Tomlins, LJ Sokoll, DW Chan, ... JAMA oncology 3 (8), 1085-1093, 2017 | 147 | 2017 |
| A systematic review of the evidence for the decipher genomic classifier in prostate cancer NK Jairath, A Dal Pra, R Vince Jr, RT Dess, WC Jackson, JJ Tosoian, ... European urology 79 (3), 374-383, 2021 | 131 | 2021 |
| Early detection of prostate cancer: AUA/SUO guideline part I: prostate cancer screening JT Wei, D Barocas, S Carlsson, F Coakley, S Eggener, R Etzioni, SW Fine, ... Journal of Urology 210 (1), 46-53, 2023 | 115 | 2023 |
| Transcriptomic heterogeneity in multifocal prostate cancer SS Salami, DH Hovelson, JB Kaplan, R Mathieu, AM Udager, NE Curci, ... JCI insight 3 (21), 2018 | 88 | 2018 |
| Appropriate use criteria for prostate-specific membrane antigen PET imaging H Jadvar, J Calais, S Fanti, F Feng, KL Greene, JL Gulley, M Hofman, ... Journal of Nuclear Medicine 63 (1), 59-68, 2022 | 86 | 2022 |
| Bringing prostate cancer germline genetics into clinical practice S Das, SS Salami, DE Spratt, SD Kaffenberger, MF Jacobs, TM Morgan Journal of Urology 202 (2), 223-230, 2019 | 63 | 2019 |
| Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer SS Salami, MA Vira, B Turkbey, M Fakhoury, O Yaskiv, R Villani, ... Cancer 120 (18), 2876-2882, 2014 | 63 | 2014 |
| Early detection of prostate cancer: AUA/SUO guideline part II: considerations for a prostate biopsy JT Wei, D Barocas, S Carlsson, F Coakley, S Eggener, R Etzioni, SW Fine, ... Journal of Urology 210 (1), 54-63, 2023 | 53 | 2023 |
| NCCN Guidelines® Insights: prostate cancer early detection, version 1.2023: featured updates to the NCCN guidelines KA Moses, PC Sprenkle, C Bahler, G Box, SV Carlsson, WJ Catalona, ... Journal of the National Comprehensive Cancer Network 21 (3), 236-246, 2023 | 52 | 2023 |
| Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors AB Zaslavsky, MP Adams, X Cao, T Maj, JE Choi, J Stangl-Kremser, ... Scientific Reports 10 (1), 19296, 2020 | 45 | 2020 |
| To clamp or not to clamp? Long‐term functional outcomes for elective off‐clamp laparoscopic partial nephrectomy PH Shah, AK George, DM Moreira, M Alom, Z Okhunov, S Salami, ... Bju International 117 (2), 293-299, 2016 | 43 | 2016 |
| Intermediate endpoints after postprostatectomy radiotherapy: 5-year distant metastasis to predict overall survival WC Jackson, K Suresh, V Tumati, SG Allen, RT Dess, SS Salami, ... European urology 74 (4), 413-419, 2018 | 41 | 2018 |
| Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation … SB Williams, S Salami, MM Regan, DP Ankerst, JT Wei, MA Rubin, ... Cancer 118 (10), 2651-2658, 2012 | 35 | 2012 |
| Biomarkers for prostate cancer detection and risk stratification MW Farha, SS Salami Therapeutic advances in urology 14, 17562872221103988, 2022 | 33 | 2022 |
| Minimally invasive inguinal lymphadenectomy in the management of penile carcinoma CM Russell, SS Salami, A Niemann, AZ Weizer, SA Tomlins, TM Morgan, ... Urology 106, 113-118, 2017 | 33 | 2017 |
Todd M. MorganUniversity of Michigan在 med.umich.edu 的电子邮件经过验证
